Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity received a formal notice from Nasdaq indicating it is not in compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q for the quarter ended March 31, 2026. The company has 60 days, until July 28, 2026, to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 days from the original due date, pushing the final deadline to November 16, 2026.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.